©The Author(s) 2026.
World J Hepatol. Feb 27, 2026; 18(2): 113004
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.113004
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.113004
Figure 7 Impact of liver enzymes on lymphocyte subsets and their percentages in coronavirus disease 2019 patients with non-alcoholic fatty liver disease: A longitudinal analysis from hospital admission to 4 weeks post-discharge.
A: Lymphocyte subset counts (cells/μL); B: Lymphocyte subset percentages (%). aP < 0.05; bP < 0.01; cP < 0.001. LY: Lymphocyte counts.
- Citation: Yan P, Li R, Yuan XY, Wang Y, Lan LJ, Yu XP, Liu DF. Dynamic immune response and its influencing factors in COVID-19 patients with non-alcoholic fatty liver disease: A cohort study. World J Hepatol 2026; 18(2): 113004
- URL: https://www.wjgnet.com/1948-5182/full/v18/i2/113004.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i2.113004